We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
+20.36%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,561.13%
AUM
$26B
AUM Growth
-$12B
(-32%)
Cap. Flow
-$15.4B
Cap. Flow
% of AUM
-59.14%
Top 10 Holdings %
Top 10 Hldgs %
26.02%
Holding
8,334
New
1,055
Increased
1,987
Reduced
3,543
Closed
1,412
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$58M |
| 2 |
Arm
ARM
|
+$57M |
| 3 |
Coinbase
COIN
|
+$30.9M |
| 4 |
Microsoft
MSFT
|
+$30.2M |
| 5 |
Amazon
AMZN
|
+$28.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$61.3M |
| 2 |
Advanced Micro Devices
AMD
|
+$58.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$54.6M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
+$35.1M |
| 5 |
Palantir
PLTR
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.22% |
| 2 | Financials | 1.78% |
| 3 | Consumer Discretionary | 1.72% |
| 4 | Healthcare | 1.04% |
| 5 | Communication Services | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OCEA
2251
CALL
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
| $831K | ﹤0.01% |
+219,500
| New | +$413K |
|
2252
Teladoc Health
TDOC
$1.66B
| $830K | ﹤0.01% |
54,969
-34,990
| -39% | -$635K |
|
|
HIVE
2253
CALL
HIVE Digital Technologies
HIVE
$678M
| $830K | ﹤0.01% |
246,200
-971,800
| -80% | -$3.47M |
|
2254
CALL
Elevance Health
ELV
$81.5B
| $830K | ﹤0.01% |
1,600
-5,600
| -78% | -$2.79M |
|
2255
CALL
NGL Energy Partners
NGL
$1.94B
| $829K | ﹤0.01% |
143,900
+114,300
| +386% | +$652K |
|
2256
PUT
Toll Brothers
TOL
$14B
| $828K | ﹤0.01% |
6,400
-22,600
| -78% | -$2.46M |
|
2257
Praxis Precision Medicines
PRAX
$8.11B
| $825K | ﹤0.01% |
13,522
+13,362
| +8,351% | +$599K |
|
2258
PUT
Pacific Biosciences
PACB
$435M
| $825K | ﹤0.01% |
220,000
-66,600
| -23% | -$390K |
|
2259
PUT
Ambev
ABEV
$47.9B
| $824K | ﹤0.01% |
332,400
+167,100
| +101% | +$435K |
|
|
MRSH
2260
PUT
Marsh
MRSH
$94.3B
| $824K | ﹤0.01% |
4,000
+3,800
| +1,900% | +$757K |
|
|
DX
2261
CALL
Dynex Capital
DX
$3.18B
| $823K | ﹤0.01% |
66,100
-4,100
| -6% | -$50.8K |
|
2262
CALL
Beam Therapeutics
BEAM
$2.68B
| $823K | ﹤0.01% |
24,900
+9,700
| +64% | +$302K |
|
2263
PUT
Ross Stores
ROST
$80.8B
| $822K | ﹤0.01% |
5,600
-19,000
| -77% | -$2.72M |
|
|
CPRX
2264
CALL
DELISTED
Catalyst Pharmaceutical
CPRX
| $821K | ﹤0.01% |
51,500
-124,900
| -71% | -$1.88M |
|
2265
Generac Holdings
GNRC
$11.5B
| $821K | ﹤0.01% |
6,506
+869
| +15% | +$102K |
|
2266
Protagonist Therapeutics
PTGX
$8.55B
| $821K | ﹤0.01% |
+28,363
| New | +$772K |
|
|
RVNC
2267
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $819K | ﹤0.01% |
166,500
+9,300
| +6% | +$55K |
|
2268
CALL
Aspen Aerogels
ASPN
$339M
| $818K | ﹤0.01% |
46,500
+34,300
| +281% | +$505K |
|
2269
PUT
BILL Holdings
BILL
$4.72B
| $818K | ﹤0.01% |
11,900
-17,400
| -59% | -$1.22M |
|
2270
CALL
Hyliion Holdings
HYLN
$578M
| $818K | ﹤0.01% |
464,600
+406,300
| +697% | +$533K |
|
2271
PUT
MGM Resorts International
MGM
$11.7B
| $817K | ﹤0.01% |
17,300
-38,500
| -69% | -$1.68M |
|
2272
PUT
Macerich
MAC
$7.4B
| $817K | ﹤0.01% |
47,400
-186,000
| -80% | -$3.03M |
|
|
2273
CALL
Toll Brothers
TOL
$14B
| $815K | ﹤0.01% |
6,300
-18,900
| -75% | -$2.06M |
|
2274
Coeur Mining
CDE
$15.1B
| $814K | ﹤0.01% |
215,793
-576,847
| -73% | -$1.66M |
|
2275
CALL
Zoom
ZM
$27.1B
| $811K | ﹤0.01% |
12,400
-718,900
| -98% | -$47.9M |
|
Similar funds
SCP
Group One Trading's Q1 2024 Portfolio in Review
As of Q1 2024, Group One Trading held 8,334 positions worth $26B, down 32% from $38B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Group One Trading withdrew a net $15.4B in Q1 2024, closing 1,412 positions and reducing 3,543 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $24.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.2% of assets, up from 2.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Group One Trading opened a new position in Arm worth $67.3M.
- Group One Trading's largest Q1 2024 buy was Arm: 538,130 shares worth $67.3M.
- Group One Trading added most to Alibaba in Q1 2024, an estimated $58M increase.
- Group One Trading's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $61.3M.
- Group One Trading fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $24.3M.
- Group One Trading's ten largest holdings make up 26% of its $26B portfolio in Q1 2024.
- Group One Trading opened 1,055 new positions and closed 1,412 in Q1 2024.
- Group One Trading's portfolio value fell 32% quarter-over-quarter to $26B.
Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.